Skip to main content
Clinical Trials/NCT06332547
NCT06332547
Not yet recruiting
Not Applicable

A Multicenter Prospective, Randomized Controlled Study of Different Transfusion Thresholds in Cardiac Valve Surgery

Guangdong Provincial People's Hospital1 site in 1 country1,600 target enrollmentApril 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Surgery With Cardiopulmonary Bypass
Sponsor
Guangdong Provincial People's Hospital
Enrollment
1600
Locations
1
Primary Endpoint
A composite of postoperative morbidity and mortality
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This prospective, randomized controlled study is aimed to figure out suitable transfusion threshold in patients undergoing cardiac valve surgery under cardiopulmonary bypass(CPB). Patients are randomly assigned to restrictive and liberal transfusion group and receive blood transfusion during and after surgery. Compare primary and secondary outcomes of two groups.

Detailed Description

Patients are randomly assigned to restrictive-threshold group and liberal-threshold group before cardiac group. Patients are included in this research when their Hct meets 24% during CPB. Arterial blood gas analysis will be done in 0.5h, 1.5h, 2.5h, 3.5h...after CPB start and 0.5h before CPB finish. Arterial blood gas analysis will be done every 4h in intensive care unit(ICU) and everyday in general ward. Restrictive-threshold group: The transfusion threshold is Hemoglobin(Hb) ≤ 6.0g/dL or Hct ≤ 18% during CPB; postoperative Hb ≤ 7.0g/dL or Hct ≤ 21% in ICU or general ward. Liberal-threshold group: The transfusion threshold is Hb ≤ 8.0g/dL or Hct ≤ 24% during CPB; postoperative Hb ≤ 10.0g/dL or Hct ≤ 30% in ICU or general ward. If the Hb or Hct fall below the threshold at any time, 2 unit of blood cells is administered as soon as possible. Test Hb or Hct again, if is under the threshold 2 unit blood cells will be given until reach the threshold.

Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
December 30, 2027
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All cardiac valve surgical patients undergoing CPB, isolated valve procedures Informed consent obtained

Exclusion Criteria

  • Pregnant or maternal women Age less than 18 years or more than 80 years Undergo coronary artery bypass or large cardiac vessels procedure Emergencies Have been attended other researches Unable to receive blood for religious reasons Drug addict or malignant tumor patient

Outcomes

Primary Outcomes

A composite of postoperative morbidity and mortality

Time Frame: Postoperative 6 months

The composite components are postoperative mortality, infectious morbidity(wound infection, septicemia, or sepsis), ischemic event(myocardial infarction, stroke, renal infraction, bowel infraction )

Secondary Outcomes

  • Number of participants with delirium(Postoperative 6 months)
  • Length of Postoperative Hospital Stay(From date of discharging from ICU until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 2 months.)
  • Number of participants with acute kidney injury(Postoperative 6 months)
  • Postoperative thoracic fluid volume in the first 24 hours(The first 24 hours after surgery)
  • Duration of mechanical ventilation(From date of the end of surgery until the date of discharging from ICU or date of death from any cause, whichever comes first, assessed up to 2 months.)
  • Rate of reoperation(Postoperative 6 months)
  • Number of Blood Transfusion(From date of beginning of surgery until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 3 months.)
  • Number of participants with new-onset renal failure with dialysis(Postoperative 6 months)
  • Length of ICU Stays(From date of the end of operation until the date of discharging from ICU or date of death from any cause, whichever comes first, assessed up to 2 months.)
  • Number of participants with postoperative atrial fibrillation(Postoperative 6 months)
  • Hospitalization expense(From date of being admitted to hospital until the date of discharging from hospital or date of death from any cause, whichever comes first, assessed up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials